I worked at Rigel & was laid off after during a reorganization after a late stage clinical failure. - Research Associate II bei Rigel Pharmaceuticals: Mitarbeiterbewertung

2.0
14. Aug. 2014
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good benefits and competitive salary. Excellent facility in a good location. Willing to promote on merit with good raises. Bonuses in good years.

Kontras

Too many Directors and Vice-Presidents. The company has a weak pipeline and the prospects for the future of the company are bleak. A lot of money is wasted on advancing weak compounds into the clinic for short term goals.

Mehr Bewertungen zu Rigel Pharmaceuticals entdecken

5.0
30. Sept. 2022
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Fantastic minds, great people, great projects

Kontras

Traffic and location, but none in the company

1.0
20. Apr. 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The pipeline of upcoming therapies is good

Kontras

The commercial analytics team operates in a challenging and often unsustainable environment. Priorities frequently shift without clear rationale, leading to reactive work cycles and limited ability to execute long-term strategy. There is a consistent gap between leadership expectations and available resources, which results in heavy workloads and a culture where long hours feel normalized. Recognition and constructive feedback are inconsistent, making it difficult for employees to understand how to grow or succeed. Concerns around management practices also impact morale. Experiences across the team suggest that junior employees and consultants are not always supported or treated with the level of respect expected in a healthy work environment. These issues are not isolated and appear to be systemic within parts of the organization.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle